Unprecedented bacterial targets are urgently needed for the development of novel antibiotics to overcome the current resistance crisis. Challenges include the limited uptake of compounds as well as prioritizing proteins for their druggability and functional relevance. Especially, the wealth of uncha...
ORGANISM(S): Pseudomonas aeruginosa Escherichia coli Staphylococcus aureus
